Foot and Mouth Disease (FMD) Vaccine
The global Foot and Mouth Disease (FMD) Vaccine market was valued at 950.61 Million USD in 2021 and will grow with a CAGR of 9.76% from 2021 to 2027, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact wwhich will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
An drug that provide immunity to the FMD.Growing livestock population and increasing demand for animal products are some of the factors contributing to the increased adoption of these vaccines globally. Livestock and zoonotic diseases are increasing over the past few decades owing to factors such as adverse climatic transformations and rapid globalization.
By Market Verdors
Agrovet market
Biogénesis Bago
Vecol
FGBI - Federal Centre for Animal Health
Indian Immunologicals
Merial
VSVRI
FMD Center
Limor de Colombia
By Types
Conventional Vaccines
Emergency Vaccines
By Applications
Cattle
Sheep and goat
Pigs
Antelope
Deer
Bison
Camelids
Key Indicators Analysed
Market Players & Competitor AnalysisThe report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market AnalysisThe report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market TrendsMarket key trends which include Increased Competition and Continuous Innovations.
Opportunities and DriversIdentifying the Growing Demands and New Technology
Porters Five Force AnalysisThe report provides with the state of competition in industry depending on five basic forcesthreat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements
Table of Content
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Foot and Mouth Disease (FMD) Vaccine Revenue
1.4 Market Analysis by Type
1.4.1 Global Foot and Mouth Disease (FMD) Vaccine Market Size Growth Rate by Type: 2021 VS 2027
1.4.2 Conventional Vaccines
1.4.3 Emergency Vaccines
1.5 Market by Application
1.5.1 Global Foot and Mouth Disease (FMD) Vaccine Market Share by Application: 2022-2027
1.5.2 Cattle
1.5.3 Sheep and goat
1.5.4 Pigs
1.5.5 Antelope
1.5.6 Deer
1.5.7 Bison
1.5.8 Camelids
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Foot and Mouth Disease (FMD) Vaccine Market
1.8.1 Global Foot and Mouth Disease (FMD) Vaccine Market Status and Outlook (2016-2027)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Foot and Mouth Disease (FMD) Vaccine Production Capacity Market Share by Manufacturers (2016-2021)
2.2 Global Foot and Mouth Disease (FMD) Vaccine Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Foot and Mouth Disease (FMD) Vaccine Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Foot and Mouth Disease (FMD) Vaccine Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Foot and Mouth Disease (FMD) Vaccine Sales Volume Market Share by Region (2016-2021)
3.2 Global Foot and Mouth Disease (FMD) Vaccine Sales Revenue Market Share by Region (2016-2021)
3.3 North America Foot and Mouth Disease (FMD) Vaccine Sales Volume
3.3.1 North America Foot and Mouth Disease (FMD) Vaccine Sales Volume Growth Rate (2016-2021)
3.3.2 North America Foot and Mouth Disease (FMD) Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.4 East Asia Foot and Mouth Disease (FMD) Vaccine Sales Volume
3.4.1 East Asia Foot and Mouth Disease (FMD) Vaccine Sales Volume Growth Rate (2016-2021)
3.4.2 East Asia Foot and Mouth Disease (FMD) Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.5 Europe Foot and Mouth Disease (FMD) Vaccine Sales Volume (2016-2021)
3.5.1 Europe Foot and Mouth Disease (FMD) Vaccine Sales Volume Growth Rate (2016-2021)
3.5.2 Europe Foot and Mouth Disease (FMD) Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.6 South Asia Foot and Mouth Disease (FMD) Vaccine Sales Volume (2016-2021)
3.6.1 South Asia Foot and Mouth Disease (FMD) Vaccine Sales Volume Growth Rate (2016-2021)
3.6.2 South Asia Foot and Mouth Disease (FMD) Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.7 Southeast Asia Foot and Mouth Disease (FMD) Vaccine Sales Volume (2016-2021)
3.7.1 Southeast Asia Foot and Mouth Disease (FMD) Vaccine Sales Volume Growth Rate (2016-2021)
3.7.2 Southeast Asia Foot and Mouth Disease (FMD) Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.8 Middle East Foot and Mouth Disease (FMD) Vaccine Sales Volume (2016-2021)
3.8.1 Middle East Foot and Mouth Disease (FMD) Vaccine Sales Volume Growth Rate (2016-2021)
3.8.2 Middle East Foot and Mouth Disease (FMD) Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.9 Africa Foot and Mouth Disease (FMD) Vaccine Sales Volume (2016-2021)
3.9.1 Africa Foot and Mouth Disease (FMD) Vaccine Sales Volume Growth Rate (2016-2021)
3.9.2 Africa Foot and Mouth Disease (FMD) Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.10 Oceania Foot and Mouth Disease (FMD) Vaccine Sales Volume (2016-2021)
3.10.1 Oceania Foot and Mouth Disease (FMD) Vaccine Sales Volume Growth Rate (2016-2021)
3.10.2 Oceania Foot and Mouth Disease (FMD) Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.11 South America Foot and Mouth Disease (FMD) Vaccine Sales Volume (2016-2021)
3.11.1 South America Foot and Mouth Disease (FMD) Vaccine Sales Volume Growth Rate (2016-2021)
3.11.2 South America Foot and Mouth Disease (FMD) Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.12 Rest of the World Foot and Mouth Disease (FMD) Vaccine Sales Volume (2016-2021)
3.12.1 Rest of the World Foot and Mouth Disease (FMD) Vaccine Sales Volume Growth Rate (2016-2021)
3.12.2 Rest of the World Foot and Mouth Disease (FMD) Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
4 North America
4.1 North America Foot and Mouth Disease (FMD) Vaccine Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Foot and Mouth Disease (FMD) Vaccine Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Foot and Mouth Disease (FMD) Vaccine Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Foot and Mouth Disease (FMD) Vaccine Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Foot and Mouth Disease (FMD) Vaccine Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Foot and Mouth Disease (FMD) Vaccine Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Foot and Mouth Disease (FMD) Vaccine Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Foot and Mouth Disease (FMD) Vaccine Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Foot and Mouth Disease (FMD) Vaccine Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Foot and Mouth Disease (FMD) Vaccine Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Foot and Mouth Disease (FMD) Vaccine Sales Volume Market Share by Type (2016-2021)
14.2 Global Foot and Mouth Disease (FMD) Vaccine Sales Revenue Market Share by Type (2016-2021)
14.3 Global Foot and Mouth Disease (FMD) Vaccine Sales Price by Type (2016-2021)
15 Consumption Analysis by Application
15.1 Global Foot and Mouth Disease (FMD) Vaccine Consumption Volume by Application (2016-2021)
15.2 Global Foot and Mouth Disease (FMD) Vaccine Consumption Value by Application (2016-2021)
16 Company Profiles and Key Figures in Foot and Mouth Disease (FMD) Vaccine Business
16.1 Agrovet market
16.1.1 Agrovet market Company Profile
16.1.2 Agrovet market Foot and Mouth Disease (FMD) Vaccine Product Specification
16.1.3 Agrovet market Foot and Mouth Disease (FMD) Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.2 Biogénesis Bago
16.2.1 Biogénesis Bago Company Profile
16.2.2 Biogénesis Bago Foot and Mouth Disease (FMD) Vaccine Product Specification
16.2.3 Biogénesis Bago Foot and Mouth Disease (FMD) Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.3 Vecol
16.3.1 Vecol Company Profile
16.3.2 Vecol Foot and Mouth Disease (FMD) Vaccine Product Specification
16.3.3 Vecol Foot and Mouth Disease (FMD) Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.4 FGBI - Federal Centre for Animal Health
16.4.1 FGBI - Federal Centre for Animal Health Company Profile
16.4.2 FGBI - Federal Centre for Animal Health Foot and Mouth Disease (FMD) Vaccine Product Specification
16.4.3 FGBI - Federal Centre for Animal Health Foot and Mouth Disease (FMD) Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.5 Indian Immunologicals
16.5.1 Indian Immunologicals Company Profile
16.5.2 Indian Immunologicals Foot and Mouth Disease (FMD) Vaccine Product Specification
16.5.3 Indian Immunologicals Foot and Mouth Disease (FMD) Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.6 Merial
16.6.1 Merial Company Profile
16.6.2 Merial Foot and Mouth Disease (FMD) Vaccine Product Specification
16.6.3 Merial Foot and Mouth Disease (FMD) Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.7 VSVRI
16.7.1 VSVRI Company Profile
16.7.2 VSVRI Foot and Mouth Disease (FMD) Vaccine Product Specification
16.7.3 VSVRI Foot and Mouth Disease (FMD) Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.8 FMD Center
16.8.1 FMD Center Company Profile
16.8.2 FMD Center Foot and Mouth Disease (FMD) Vaccine Product Specification
16.8.3 FMD Center Foot and Mouth Disease (FMD) Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.9 Limor de Colombia
16.9.1 Limor de Colombia Company Profile
16.9.2 Limor de Colombia Foot and Mouth Disease (FMD) Vaccine Product Specification
16.9.3 Limor de Colombia Foot and Mouth Disease (FMD) Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
17 Foot and Mouth Disease (FMD) Vaccine Manufacturing Cost Analysis
17.1 Foot and Mouth Disease (FMD) Vaccine Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Foot and Mouth Disease (FMD) Vaccine
17.4 Foot and Mouth Disease (FMD) Vaccine Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Foot and Mouth Disease (FMD) Vaccine Distributors List
18.3 Foot and Mouth Disease (FMD) Vaccine Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Foot and Mouth Disease (FMD) Vaccine (2022-2027)
20.2 Global Forecasted Revenue of Foot and Mouth Disease (FMD) Vaccine (2022-2027)
20.3 Global Forecasted Price of Foot and Mouth Disease (FMD) Vaccine (2016-2027)
20.4 Global Forecasted Production of Foot and Mouth Disease (FMD) Vaccine by Region (2022-2027)
20.4.1 North America Foot and Mouth Disease (FMD) Vaccine Production, Revenue Forecast (2022-2027)
20.4.2 East Asia Foot and Mouth Disease (FMD) Vaccine Production, Revenue Forecast (2022-2027)
20.4.3 Europe Foot and Mouth Disease (FMD) Vaccine Production, Revenue Forecast (2022-2027)
20.4.4 South Asia Foot and Mouth Disease (FMD) Vaccine Production, Revenue Forecast (2022-2027)
20.4.5 Southeast Asia Foot and Mouth Disease (FMD) Vaccine Production, Revenue Forecast (2022-2027)
20.4.6 Middle East Foot and Mouth Disease (FMD) Vaccine Production, Revenue Forecast (2022-2027)
20.4.7 Africa Foot and Mouth Disease (FMD) Vaccine Production, Revenue Forecast (2022-2027)
20.4.8 Oceania Foot and Mouth Disease (FMD) Vaccine Production, Revenue Forecast (2022-2027)
20.4.9 South America Foot and Mouth Disease (FMD) Vaccine Production, Revenue Forecast (2022-2027)
20.4.10 Rest of the World Foot and Mouth Disease (FMD) Vaccine Production, Revenue Forecast (2022-2027)
20.5 Forecast by Type and by Application (2022-2027)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)
20.5.2 Global Forecasted Consumption of Foot and Mouth Disease (FMD) Vaccine by Application (2022-2027)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Foot and Mouth Disease (FMD) Vaccine by Country
21.2 East Asia Market Forecasted Consumption of Foot and Mouth Disease (FMD) Vaccine by Country
21.3 Europe Market Forecasted Consumption of Foot and Mouth Disease (FMD) Vaccine by Countriy
21.4 South Asia Forecasted Consumption of Foot and Mouth Disease (FMD) Vaccine by Country
21.5 Southeast Asia Forecasted Consumption of Foot and Mouth Disease (FMD) Vaccine by Country
21.6 Middle East Forecasted Consumption of Foot and Mouth Disease (FMD) Vaccine by Country
21.7 Africa Forecasted Consumption of Foot and Mouth Disease (FMD) Vaccine by Country
21.8 Oceania Forecasted Consumption of Foot and Mouth Disease (FMD) Vaccine by Country
21.9 South America Forecasted Consumption of Foot and Mouth Disease (FMD) Vaccine by Country
21.10 Rest of the world Forecasted Consumption of Foot and Mouth Disease (FMD) Vaccine by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices